Anticipatory Medicine
Mi Salud Genómica
In 2024, we took our commitment to prevention a step further with the launch of Mi Salud Genómica, introducing advanced genetics into our healthcare offering. This pioneering preventive medicine programme sequences, interprets and analyses the human genome to detect potential genetically predisposed conditions—such as certain types of cancer or type 2 diabetes, among many others.
Personalised Medicine
At Sanitas, we believe in medicine that adapts to each person’s individual characteristics and anticipates their needs. We rely on whole genome sequencing to study each patient’s genetic information and identify mutations or alterations in genes associated with current or future health risks.
Personalised Medicine
Mi Salud Genómica is a programme led by Sanitas and Bupa UK, with plans to expand to other countries in the near future. In its first phase, the programme will sequence the genomes of approximately 14,000 individuals, making it the largest genomic sequencing and preventive healthcare initiative in Europe.
5P Medicine Model
01.
Preventive
A proactive approach enables us to care for health by preventing disease before it occurs.
02.
Personalised
The power of genetic data allows us to tailor each health plan or medical treatment to the individual needs of each patient.
03.
Precise
Genetic information provides a high level of diagnostic accuracy, supporting better clinical decision-making.
04.
Predictive
Genomic analysis is key to identifying latent health risks that may emerge in the future.
05.
Participatory
Using DNA insights to actively manage one’s health empowers the patient.
Key figures
samples
+2,700
showed a clinically relevant genetic variant
17.5%
of participants were identified as being at risk of developing a serious but preventable disease
3.7%
of participants were found to have interactions with medication
100%